Tietze syndrome - a case report of 20 year old male patient with steroid induced tinea incognito

Tietze syndrome is a self-limiting, rare and benign condition that might be mistaken with potentially fatal chest diseases and misdiagnosed mostly as costochondritis. This disease is most often diagnosed in young individuals under the age of 40, with painful, localized inflammation.Tinea incognito is a ringworm infection that has been altered by corticosteroids and other immunosuppressive medications. Corticosteroids are administered for pre-existing illness or are used incorrectly for the treatment of tinea. We report a case of 20years old male patient admitted in emergency department with complaints of chest pain and SOB with normal ECG while neutrophils, ESR, CRP have found to be abnormal. Patient has been using steroids and itraconazole for maculopapular rashes in lower limb since 1year. Other diagnostic methods such as CT, MRI should be performed to avoid misdiagnosis. He was prescribed with NSAIDS, antifungals, antihistamines and other supportive measures which helped him to relieve from pain. Proper diagnostic criteria and early diagnosis remain challenging tasks, resulting in undue treatment costs for patients. Before confirming a diagnosis, other underlying diseases should be ruled out.

Tietze Sendromu: Bir Olgu Sunumu

Tietze’s Syndrome: A Case Report Tietze syndrome (TS) is a rare inflammatory arthropathy characterized by tenderness, pain, and non-purulent swelling of the costosternal, costochondral and sternoclavicular joints. It often involves the costosternal joints and sternoclavicular jointinvolvement is rare. In this case report, we present a 72-year-old female patient suffering from pain and swelling in the right upper chest wall fo rabout 2 years. Physical examination revealed tenderness in the right sternoclavicular joint and an approximately 2x2 cm moderate swelling. Ultrasonic imaging of the swelling area revealed increased echogenicity and edema in the right sternoclavicular joint area. Laboratory findings were normal. The patient was diagnosed with TS and a local injection of a corticosteroid and local anesthetic mixture was administered. The patient’s complaints decreased significantly after the infiltration. In this case report, we present a TS case with sternoclavicular joint involvement that we treated with local injection. Keywords: Tietze’s syndrome, sternoclavicularjoint, costochondritis

A Retrospective, Single-Center Study Investigating the Effects of a Novel Miniature Wireless Spinal Cord Stimulation System for the Treatment of Chronic Back and Leg Pain

BACKGROUND: Tietze syndrome is believed to be a result of recurrent microtrauma and characterized by painful localized inflammation and swelling of the chest wall. Chronic inflammatory changes may infiltrate surrounding tissues, leading to nerve root irritation and subsequent neuralgia. Resultant chronic neuropathy has been historically treated with conservative therapies and local nerve blocks, but the role of implantable neurostimulators have not been well described. CASE REPORT: A 73-year-old woman presented with chronic pain in the left paracentral chest area with episodes of burning and tingling, which radiated to the left shoulder, left arm, and left upper side of the jaw and face. Following the implantation of a permanent neurostimulator, the patient reported a near complete resolution of her pain symptoms. CONCLUSION: The role of implantable neurostimulators in the treatment of chronic neuropathy in the setting of Tietze syndrome is promising and their use may become a mainstay option in the future. KEY WORDS: Tietze Syndrome, neuromodulation, spinal cord nerve stimulation, pain management, neuralgia, implantable spinal cord stimulator

Local treatment of pain in Tietze syndrome: A single-center experience

Background: In this study, we present our experiences with local injections of triamcinolone and prilocaine in patients diagnosed with Tietze syndrome. Methods: Between January 2016 and January 2019, a total of 28 patients (12 males, 16 females; median age: 33 years; range, 21 to 51 years) who were diagnosed with TS in our clinic were retrospectively analyzed. Triamcinolone hexacetonide and prilocaine hydrochloride were injected into painful joints. At first week, pain sensation of the patients was recorded using the Pain Rating Scale developed by the British Pain Society. Pain was also assessed at one, two, and three weeks after injections qualitatively and based on physical examination. Results: At one week, the pain severity before the local injection treatment was above average the pain-related discomfort rates, and the response was quite favorable after the treatment (p=0.005 and p=0.001, respectively). A statistically significant rating was observed for treatment response and success (p=0.003). Totally 75% of the patients experienced more than 70% reduction in pain level after the injection. Conclusion: Our treatment approach involving injection of a mixture of steroid and a local anesthetic provides a rapid relief from pain, irrespective of age, sex, or employment status in patients diagnosed with Tietze syndrome.